Keyphrases
Finland
100%
Pneumococcal Conjugate Vaccine
100%
PCV10
100%
Pneumococcal Meningitis
100%
Population Effects
100%
Confidence Interval
36%
Fatality
18%
Parameter Estimation
9%
Rate Difference
9%
Age Groups
9%
ICD-10
9%
Older Adults
9%
Mortality Rate
9%
Program Impact
9%
Cerebrospinal Fluid
9%
Meningitis
9%
Age-specific
9%
Poisson Regression
9%
Streptococcus Pneumoniae
9%
30-day Mortality
9%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
9%
S. Pneumoniae
9%
Vaccine Serotypes
9%
Serotype Distribution
9%
Serotype Replacement
9%
Bacterial Meningitis
9%
Positive Culture
9%
Delta Method
9%
Hospital Discharge Diagnosis
9%
Herd Protection
9%
Serotype-specific
9%
Absolute Rates
9%
Mortality Distribution
9%
Population-based Observational Studies
9%
Impact Protection
9%
Medicine and Dentistry
Pneumococcal Meningitis
100%
Serotype
77%
Mortality Rate
22%
Case Fatality Rate
22%
Observational Study
11%
Cerebrospinal Fluid
11%
Meningitis
11%
ICD-10
11%
Pneumococcus Vaccine
11%
Pneumococcus
11%
Herd
11%
Bacterial Meningitis
11%
Program Impact
11%
Streptococcus Pneumonia
11%
Pneumococcal Pneumonia
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pneumococcal Meningitis
100%
Mortality Rate
22%
Case Fatality Rate
22%
Meningitis
11%
Observational Study
11%
Pneumococcus Vaccine
11%
ICD-10
11%
Bacterial Meningitis
11%
Streptococcus Pneumonia
11%